Clinical Trial Update: A Study To Compare Effects Of GSK189075 In Combination With Either Furosemide Or Hydrochlorothiazide [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating GSK189075 in combination with either furosemide or hydrochlorothiazide in people with Type 2 diabetes mellitus; the trial status is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• FUROSEMIDE (Furosemide)
• GSK189075 (GSK189075)
• HYDROCHLOROTHIAZIDE (hydrochlorothiazide)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Type 2 Diabetes Mellitus, Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED